Daisuke Nishi Selected Research

Ashwagandha

7/2022

Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daisuke Nishi Research Topics

Disease

15	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2017 - 01/2009
6	Accidental Injuries 12/2017 - 04/2009
4	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 01/2013
3	COVID-19 01/2024 - 01/2023
3	Wounds and Injuries (Trauma) 01/2023 - 01/2013
2	Hemorrhage 01/2023 - 11/2021
2	Acute Coronary Syndrome 01/2023 - 01/2017
2	Mental Disorders (Mental Disorder) 07/2022 - 01/2017
1	Cardiac Tamponade 10/2023
1	Ovarian Neoplasms (Ovarian Cancer) 10/2023
1	Neoplasms (Cancer) 10/2023
1	Pericardial Effusion 10/2023
1	Pleural Effusion (Pleural Effusions) 10/2023
1	Death (Near-Death Experience) 01/2023
1	Diabetes Mellitus 01/2023
1	Hypoglycemia (Reactive Hypoglycemia) 01/2023
1	Myocardial Infarction 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Anxiety Disorders (Anxiety Disorder) 07/2022
1	Depressive Disorder (Melancholia) 07/2022
1	Mood Disorders (Mood Disorder) 07/2022
1	Psychotic Disorders (Schizoaffective Disorder) 07/2022
1	Schizophrenia (Dementia Praecox) 07/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2022
1	Postpartum Depression (Post-Natal Depression) 04/2021
1	Poisoning 08/2017
1	Heart Failure 08/2017
1	Substance-Related Disorders (Drug Abuse) 12/2015
1	Malnutrition (Nutritional Deficiencies) 03/2015

Drug/Important Bio-Agent (IBA)

7	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 07/2022 - 04/2010
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2017 - 01/2009
3	Docosahexaenoic AcidsIBA 12/2017 - 01/2015
3	Eicosapentaenoic AcidIBA 12/2017 - 01/2015
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013 - 01/2011
2	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 12/2023 - 01/2023
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2022 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2013
1	pembrolizumabIBA 10/2023
1	PlatinumIBA 10/2023
1	Antidepressive Agents (Antidepressants)IBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Methionine (L-Methionine)FDA Link 07/2022
1	MicronutrientsIBA 07/2022
1	CurcuminIBA 07/2022
1	Therapeutic UsesIBA 07/2022
1	Acetylcarnitine (Alcar)IBA 07/2022
1	Vitamin D FDA LinkGeneric 07/2022
1	AshwagandhaIBA 07/2022
1	ZincIBA 07/2022
1	Hemostatics (Antihemorrhagics)IBA 11/2021
1	Cardiovascular AgentsIBA 08/2017
1	BenzodiazepinesIBA 08/2017
1	Linoleic Acid (Linoleate)IBA 01/2017
1	ORALIT (ORS)IBA 01/2017
1	Glutamine (L-Glutamine)FDA Link 12/2015
1	Glutamic Acid (Glutamate)FDA Link 12/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2015
1	Neuropeptide YIBA 06/2014
1	Propofol (Diprivan)FDA LinkGeneric 10/2012
1	Fish OilsIBA 12/2011

Therapy/Procedure

5	Secondary Prevention 12/2017 - 04/2010
4	Therapeutics 01/2023 - 03/2015
1	Personal Protective Equipment 01/2024
1	Stents 01/2023
1	Drug-Eluting Stents 01/2023
1	Nuclear Power Plants 01/2023
1	Percutaneous Coronary Intervention 01/2023
1	Diet Therapy (Therapy, Diet) 12/2015
1	Critical Care (Surgical Intensive Care) 04/2009